Dr Thomas Seyfried has shown that cancer is a metabolic disease, not a genetic disease as is currently accepted by mainstream cancer researchers and oncologists. Dr Seyfried says that cancer lives off glucose and glutamine and when these are not available to the cancer it dies. He uses four very cheap available drugs to block the glutamine at regular intervals and manages the glucose with diet and blood tests. The protocol developed by him and others also uses hypobaric oxygen tanks to infuse the cells with oxygen which helps break up the tumors. The success rate is very high. Watch this whole video and read the notes below to find out how to contact a Dr or Nutritionist or guide to help with this kind of treatment.
Source https://www.youtube.com/watch?v=pm2ia_Nsfc8&t=10s
Feb 29, 2024 NEW UPLOADS
This interview is for informational purposes and should not be used in place of an actual doctor's visit. Always work with your healthcare provider before making significant changes to your health or medical treatment plan.
Dr. Thomas Seyfried's groundbreaking research approaches cancer as a metabolic dysfunction and addresses its root cause. Although controversial, this approach has provided hope for practitioners and cancer patients. Today’s guests highlight the work of the Hippocrates Research Foundation, a non-profit that continues Dr. Seyfried’s work by helping cancer patients combat their disease through education on metabolic approaches to treatment.
Today on The Dhru Purohit Podcast, Dhru sits down with Den Stacey, who, after being diagnosed with Stage 4 cancer, embarked on a journey seeking guidance from the Hippocrates Research Foundation and ultimately became cancer-free. The HRF Team of Daniel Orrego, Dr. Gregory Howard, and Dr. Michelle Howard describe their research and approach to guiding those diagnosed with cancer, including implementing a protocol that starves the cancer and fuels the body.
Daniel Orrego is a Co-Founder of the Hippocrates Research Foundation. Daniel is advancing a platform of patient advocacy, education, and facilitation to ensure that a broader public can access best-in-class health care in partnership with their physician.
Dr. Gregory Howard and Dr. Michelle Howard are co-founders of the Hippocrates Research Foundation, which studies cancer prevention. They used liquid biopsies to diagnose Dr. Michelle Howard’s stage zero melanoma and ovarian cancers and implemented non-toxic metabolic therapies to keep her cancer in check.
In this episode, Dhru, Den, Daniel, and Drs. Gregory & Michelle Howard dive into:
-Den’s email to Dhru that led to this remarkable conversation
-How the Hippocrates Research Foundation came about
-Treating dogs with cancer through metabolic treatment
-The protocol and how individuals seek out treatment
-Critical disclaimers
-Den’s journey and treatment
-Dr. Seyfried’s view of cancer versus the traditional view of cancer
-The precision required from the patient to stick to the protocol
-Starving the cancer while fueling the body: The protocol
-An ideal team to combat a cancer diagnosis
-Den’s journey to no evidence of disease
-The pros and cons of liquid biopsies in cancer prevention
-The tools used in stress management, mitochondrial support, and overall health
-The next steps to implement Dr. Seyfried’s work on a larger scale
-Tips on prevention and protecting your mitochondria
Also mentioned in this episode:
-Den’s Study: https://www.dropbox.com/scl/fi/nb3rho...
-Hippocrates Research Foundation: https://hippocratesresearchfoundation...
-Self Rescue Society: https://selfrescuesociety.com/
-Dr. Seyfried’s Book: https://a.co/d/6CNifb8
This episode is brought to you by:
-Bioptimizers: http://bioptimizers.com/dhru
-Lumebox: https://thelumebox.com/dhru
Go to http://bioptimizers.com/dhru now and enter promo code DHRU10 to get 10% off any order and up to 2 travel-size bottles of Magnesium Breakthrough for a limited time.
Lumebox is offering my community $260 off their FDA-approved portable Red Light device! That's over 50% off! Go to https://thelumebox.com/dhru and get your Red Light device.
